We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$281M
AUM Growth
+$47.6M
Cap. Flow
+$23.4M
Cap. Flow %
8.3%
Top 10 Hldgs %
45.9%
Holding
164
New
35
Increased
26
Reduced
12
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APGN
126
DELISTED
Apexigen, Inc. Common Stock
APGN
$40K 0.01%
4,000
HCAQ
127
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$39K 0.01%
4,000
CC icon
128
Chemours
CC
$2.35B
$32K 0.01%
920
EXP icon
129
Eagle Materials
EXP
$6.06B
$32K 0.01%
228
BNS icon
130
Scotiabank
BNS
$113B
$26K 0.01%
400
PBCT
131
DELISTED
People's United Financial Inc
PBCT
$26K 0.01%
1,500
APGNW
132
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$23K 0.01%
2,000
ACQRW
133
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$22K 0.01%
+1,900
New +$1.81K
VRCA icon
134
Verrica Pharmaceuticals
VRCA
$97.7M
$16K 0.01%
138
-7,704
-98% -$933K
SVC
135
Service Properties Trust
SVC
$1.02B
$13K ﹤0.01%
200
VTRS icon
136
Viatris
VTRS
$18.8B
$11K ﹤0.01%
794
+546
+220% +$7.9K
STWD icon
137
Starwood Property Trust
STWD
$5.85B
$10K ﹤0.01%
400
OXY.WS icon
138
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$8K ﹤0.01%
370
SCU
139
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$5K ﹤0.01%
200
AMLP icon
140
Alerian MLP ETF
AMLP
$13.4B
$4K ﹤0.01%
120
OGN icon
141
Organon & Co
OGN
$3.61B
$4K ﹤0.01%
+130
New +$4.28K
RMR icon
142
The RMR Group
RMR
$332M
$1K ﹤0.01%
16
WAB icon
143
Wabtec
WAB
$49.4B
$1K ﹤0.01%
17
BCRX icon
144
BioCryst Pharmaceuticals
BCRX
$2.51B
-30,703
Closed -$312K
FLL icon
145
Full House Resorts
FLL
$75.5M
-50,000
Closed -$426K
IBB icon
146
iShares Biotechnology ETF
IBB
$10.5B
-1,000
Closed -$151K
DOMA
147
DELISTED
Doma Holdings, Inc.
DOMA
-10,000
Closed -$2.52M
ACQRU
148
DELISTED
Independence Holdings Corp. Units
ACQRU
-9,500
Closed -$95K
LOKM.U
149
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
-360,152
Closed -$3.59M
IBER.U
150
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
-36,000
Closed -$355K

Similar funds

David M. Knott's Q2 2021 Portfolio in Review

As of Q2 2021, David M. Knott held 164 positions worth $281M, up 20% from $234M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

David M. Knott deployed $23.4M of net new capital in Q2 2021, opening 35 new positions and adding to 26 existing holdings. Its largest new stake was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 23% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Gilead Sciences, an estimated $2.37M trimmed.

  • David M. Knott's largest Q2 2021 buy was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
  • David M. Knott added most to Calumet Specialty Products in Q2 2021, an estimated $1.9M increase.
  • David M. Knott's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $2.37M.
  • David M. Knott fully exited African Gold Acquisition Corp Units in Q2 2021, selling an estimated $6.11M.
  • David M. Knott's ten largest holdings make up 46% of its $281M portfolio in Q2 2021.
  • David M. Knott opened 35 new positions and closed 17 in Q2 2021.
  • David M. Knott's portfolio value rose 20% quarter-over-quarter to $281M.

Based on David M. Knott's 13F filing for Q2 2021, filed 13 Aug 2021.